Key facts
- This page summarizes Leon Recanati's Form 4 filing for Evogene Ltd. (EVGN).
- 1 reported transaction and 3 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2026, 16:07.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The price reported in column 4 of this row is a weighted average price. These shares were purchased in multiple transactions on August 4, 2026 within a range of prices per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Footnote F2
There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Footnote F3
The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested on the one-year anniversary of the August 18, 2025 grant date.
SEC remarks
Exhibit 24.1 - Power of Attorney.